Napolitano M - Search Results

1

Glial cell line-derived neurotrophic factor induces proliferative inhibition of NT2/D1 cells through RET-mediated up-regulation of the cyclin-dependent kinase inhibitor p27(kip1).

Baldassarre G, Bruni P, Boccia A, Salvatore G, Melillo RM, Motti ML, Napolitano M, Belletti B, Fusco A, Santoro M, Viglietto G. Baldassarre G, et al. Among authors: napolitano m. Oncogene. 2002 Mar 7;21(11):1739-49. doi: 10.1038/sj.onc.1205226. Oncogene. 2002. PMID: 11896605

2

The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes.

Carlomagno F, Vitagliano D, Guida T, Napolitano M, Vecchio G, Fusco A, Gazit A, Levitzki A, Santoro M. Carlomagno F, et al. Among authors: napolitano m. Cancer Res. 2002 Feb 15;62(4):1077-82. Cancer Res. 2002. PMID: 11861385

3

Fe65, a ligand of the Alzheimer's beta-amyloid precursor protein, blocks cell cycle progression by down-regulating thymidylate synthase expression.

Bruni P, Minopoli G, Brancaccio T, Napolitano M, Faraonio R, Zambrano N, Hansen U, Russo T. Bruni P, et al. Among authors: napolitano m. J Biol Chem. 2002 Sep 20;277(38):35481-8. doi: 10.1074/jbc.M205227200. Epub 2002 Jun 27. J Biol Chem. 2002. PMID: 12089154 Free article.

4

Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas.

Motti ML, Califano D, Baldassarre G, Celetti A, Merolla F, Forzati F, Napolitano M, Tavernise B, Fusco A, Viglietto G. Motti ML, et al. Among authors: napolitano m. Carcinogenesis. 2005 Jun;26(6):1021-34. doi: 10.1093/carcin/bgi050. Epub 2005 Feb 17. Carcinogenesis. 2005. PMID: 15718252

5

The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib.

Normanno N, De Luca A, Maiello MR, Campiglio M, Napolitano M, Mancino M, Carotenuto A, Viglietto G, Menard S. Normanno N, et al. Among authors: napolitano m. J Cell Physiol. 2006 May;207(2):420-7. doi: 10.1002/jcp.20588. J Cell Physiol. 2006. PMID: 16419029

6

In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies.

Ieranò C, Righelli D, D'Alterio C, Napolitano M, Portella L, Rea G, Auletta F, Santagata S, Trotta AM, Guardascione G, Liotti F, Prevete N, Maiolino P, Luciano A, Barbieri A, Di Mauro A, Roma C, Esposito Abate R, Tatangelo F, Pacelli R, Normanno N, Melillo RM, Scala S. Ieranò C, et al. Among authors: napolitano m. J Immunother Cancer. 2022 Mar;10(3):e004032. doi: 10.1136/jitc-2021-004032. J Immunother Cancer. 2022. PMID: 35246475 Free PMC article.

7

Effects of the combined blockade of EGFR and ErbB-2 on signal transduction and regulation of cell cycle regulatory proteins in breast cancer cells.

D'Alessio A, De Luca A, Maiello MR, Lamura L, Rachiglio AM, Napolitano M, Gallo M, Normanno N. D'Alessio A, et al. Among authors: napolitano m. Breast Cancer Res Treat. 2010 Sep;123(2):387-96. doi: 10.1007/s10549-009-0649-x. Epub 2009 Nov 28. Breast Cancer Res Treat. 2010. PMID: 19946741

8

The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma.

Pivonello C, Negri M, De Martino MC, Napolitano M, de Angelis C, Provvisiero DP, Cuomo G, Auriemma RS, Simeoli C, Izzo F, Colao A, Hofland LJ, Pivonello R. Pivonello C, et al. Among authors: napolitano m. Oncotarget. 2016 Mar 1;7(9):9718-31. doi: 10.18632/oncotarget.6836. Oncotarget. 2016. PMID: 26756219 Free PMC article.

9

AZD3409 inhibits the growth of breast cancer cells with intrinsic resistance to the EGFR tyrosine kinase inhibitor gefitinib.

Maiello MR, D'Alessio A, De Luca A, Carotenuto A, Rachiglio AM, Napolitano M, Cito L, Guzzo A, Normanno N. Maiello MR, et al. Among authors: napolitano m. Breast Cancer Res Treat. 2007 May;102(3):275-82. doi: 10.1007/s10549-006-9340-7. Epub 2006 Sep 27. Breast Cancer Res Treat. 2007. PMID: 17004112

10

Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer.

Camorani S, Hill BS, Collina F, Gargiulo S, Napolitano M, Cantile M, Di Bonito M, Botti G, Fedele M, Zannetti A, Cerchia L. Camorani S, et al. Among authors: napolitano m. Theranostics. 2018 Oct 6;8(18):5178-5199. doi: 10.7150/thno.27798. eCollection 2018. Theranostics. 2018. PMID: 30429893 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

990 results

Search Page

Filters